A Fresh Business Model for Biotech in Baltimore

Summary

---

When it comes to biotechnology, Maryland is known for having a number of promising startup companies rather than late-stage firms. A reality of the marketplace, however, is that venture capitalists are not inclined to fund these companies, which leaves them on their own to raise money. And doing that is a difficult proposition, not to mention a distinct distraction from getting products from the laboratory to market in a timely manner.

However, the Greater Baltimore Committee expects to debut a new company in the near future to tackle that very issue: Chesapeake BioDiscovery Partners.

See the full content of this document

Extract

---

A Fresh Business Model for Biotech in Baltimore

"Originally, the GBC set out to identify gaps in the bioscience industry that needed to be addressed," says Lisbeth Pettengill, GBC's vice president. "What we found ...

See the full content of this document

---